tert-butyl 1-(4-(4-phenyl-2,6-naphthyridin-3-yl)phenyl)cyclobutylcarbamate | 1357159-48-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: tert-butyl 1-(4-(4-phenyl-2,6-naphthyridin-3-yl)phenyl)cyclobutylcarbamate
• CAS: 1357159-48-8
• 化学式: C₂₉H₂₉N₃O₂
• 分子量: 451.568
• InChiKey: QOMTYMRUEPTRPJ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  6.87
• 重原子数：
  34.0
• 可旋转键数：
  4.0
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.28
• 拓扑面积：
  64.11
• 氢给体数：
  1.0
• 氢受体数：
  4.0

反应信息

• 作为反应物：
  描述：

  tert-butyl 1-(4-(4-phenyl-2,6-naphthyridin-3-yl)phenyl)cyclobutylcarbamate 在 盐酸 作用下， 以 1,4-二氧六环 、 二氯甲烷 为溶剂， 反应 0.25h， 以91%的产率得到1-(4-(4-phenyl-2,6-naphthyridin-3-yl)phenyl)cyclobutanamine
  参考文献：
  名称：

  Diverse Heterocyclic Scaffolds as Allosteric Inhibitors of AKT

  摘要：

  Wide-ranging exploration of potential replacements for a quinoline-based inhibitor of activation of AKT kinase led to number of alternative, novel scaffolds with potentially improved potency and physicochemical properties. Examples showed predictable DMPK properties, and one such compound demonstrated pharmacodynamic knockdown of phosphorylation of AKT and downstream biomarkers in vivo and inhibition of tumor growth in a breast cancer xenograft model.

  DOI：

  10.1021/jm201394e
• 作为产物：
  描述：

  tert-butyl 1-(4-((4-formylpyridin-3-yl)ethynyl)phenyl)cyclobutylcarbamate 在 2-双环己基膦-2',6'-二甲氧基联苯 、 potassium dihydrogenphosphate 、 palladium diacetate 、 三乙胺 、 copper dichloride 作用下， 以 二氯甲烷 、 N,N-二甲基乙酰胺 、 甲苯 为溶剂， 反应 11.0h， 生成 tert-butyl 1-(4-(4-phenyl-2,6-naphthyridin-3-yl)phenyl)cyclobutylcarbamate
  参考文献：
  名称：

  Diverse Heterocyclic Scaffolds as Allosteric Inhibitors of AKT

  摘要：

  Wide-ranging exploration of potential replacements for a quinoline-based inhibitor of activation of AKT kinase led to number of alternative, novel scaffolds with potentially improved potency and physicochemical properties. Examples showed predictable DMPK properties, and one such compound demonstrated pharmacodynamic knockdown of phosphorylation of AKT and downstream biomarkers in vivo and inhibition of tumor growth in a breast cancer xenograft model.

  DOI：

  10.1021/jm201394e